Alberta health organizations and universities team up to optimize analysis of real world data to inform decision-making

By | Consortium Updates, News | No Comments

The Institute of Health Economics, the University of Alberta, and the University of Calgary are pleased to announce the creation of the Alberta Real World Evidence C onsortium – . The mandate of the Consortium is to support the development of quality real world evidence generation and utilization.

Real World Evidence (RWE) studies investigate the impact of an intervention or technology on health outcomes and resource utilization in clinical conditions outside of the controlled clinical trial setting. The evidence is generated from routinely collected health data to evaluate the safety, effectiveness, and value of newly introduced or existing health technologies and/or other interventions.

Alberta has one of the largest, most mature, detailed and comprehensive health system data depositories in Canada. As such, Alberta is poised to become a global leader in RWE generation. To realize this potential, the Universities of Alberta and Calgary, along with the Institute of Health Economics, have led the formation of the Alberta RWE Consortium. Consortium membership also includes Alberta Innovates, Alberta Health, Alberta Economic Development and Trade, and Alberta Health Services.

Alberta is a leader in health innovation. With Canada’s largest integrated health delivery system and this new consortium, we are set to take a leadership role in RWE research. The University of Alberta is excited to gain new insights to streamline and improve health care through real world data,” said Dr. Lawrence Richer, Associate Dean, Clinical & Translational Research, University of Alberta.

Through the Alberta RWE Consortium, industry and other health system partners have access to coordinated resources, expertise, processes, and data that ensures high-quality RWE studies.

Key functions of the Consortium include:

  1. Optimization of Alberta’s RWE studies
  2. Strengthening the Alberta RWE ecosystem
  3. Providing world class project support services, including study design, execution, and knowledge sharing
  4. Identifying and supporting projects that align with provincial health and policy priorities, ensuring relevance to decision-makers in Alberta
  5. Convening the best pan-provincial teams for commissioned, large-scale projects that may also have implementation components

The RWE consortium will help foster cutting-edge health research with industry and other health sector partners interested in real world data applications in Alberta,” said Dr. Marcello Tonelli, Associate Vice President, Research, University of Calgary, “This will guide health care investment, making policy more effective and impactful.

RWE is playing a growing role in technology adoption, as well as health policy and clinical practice decision-making, recognizing some of the limitations of traditional controlled clinical trials. Governments and health service providers are using RWE to improve health outcomes in priority areas, and to monitor the post-market safety and effectiveness of new or existing health technologies and innovations. This information is also being used to support coverage and procurement decisions, as well as to assess return-on-investment of public dollars. Additionally, clinicians are increasingly using this information in the development of clinical guidelines and decision-support tools, and, with quality RWE, technology developers may improve market access over time.

As a trusted convener, the Institute of Health Economics has a long-standing history of fostering collaborative partnerships. As Secretariat to the RWE consortium, the IHE will support the optimization of quality RWE research in Alberta,” said Dr. Christopher McCabe, Executive Director and CEO, Institute of Health Economics.

Albertans place a high value on their right to privacy and confidentiality. The province protects and controls health system data through a rigorous data-protection regulatory framework. Those working on Consortium-led projects (e.g., data custodians and researchers) are legally obligated to be in strict compliance with provincial and federal privacy legislation, as well as established organizational privacy and security policies. For more information about the Consortium, its suite of services, and its privacy and security measures, please visit

Jasmine Brown
Director of Communications, Institute of Health Economics
Office: (780) 401-1768 | Cell: (780) 966-4879 | Email: [email protected]

Shelby Soke Communications Associate
Faculty of Medicine & Dentistry, University of Alberta Office: (780) 492-0647 | Email: [email protected]

Jenny McLean
Communications and Marketing Specialist
Office of the Vice-President, University of Calgary
Office: (403) 210-3992 | Email: [email protected]

ISPOR Educational Webinar: Leveraging Data Science and Innovative Digital Technologies to Optimize Real World Evidence Generation

By | News | No Comments

ISPOR will be offering a new, complimentary educational webinar on June 12th, Leveraging Data Science and Innovative Digital Technologies to Optimize Real World Evidence Generation. The webinar is open to all – ISPOR members and non-members – so please join us and forward to colleagues who could benefit.

Real world evidence is playing an increasingly important role in HEOR and healthcare decision-making. However, the diverse nature and sheer volume of real world data presents a number of challenges to healthcare and life sciences organizations aspiring to leverage real world evidence to, respectively, improve patient clinical outcomes, and demonstrate the safety and value of pharmaceutical products.

Whether it’s structured, multi-structured, or unstructured, today’s real world data presents a barrier to insight because it is derived from a wide-variety of sources – including electronic health records, genomics data, sensors, wearable devices, etc. – and stored across disconnected silos that make it difficult to integrate and transform this disparate information for analysis and insights. In this webinar, we’ll discuss how data science and digital data technologies are empowering organizations to overcome these obstacles while transforming the way real world evidence is generated and used.

Presented by:

Jyotsna Mehta, Founder, KEVA Health, (Knowledge Evidence Value Access)
Bill Fox, Chief Strategist, Global Healthcare, Life Sciences and Insurance, MarkLogic
Dr. Javier Jimenez, Vice President & Global Head RWE and Clinical Outcomes, Sanofi
Dr. Ashish Atreja, Chief Innovation Officer, Medicine, Mount Sinai Health System
Sponsored by MarkLogic

Event Details:

Tuesday, June 12, 2018 10:00 am
Easter Daylight Time (New York, GMT-4:00)

Participation is open to everyone – members and non-members of ISPOR. Reservations are on a first-come, first-served basis. Only the first 500 participants to login to the webinar will be able to see it.

Webinar Link:

Biologics/Biosimilar Project

By | News, Project Updates | No Comments

The Alberta RWE Consortium is pleased to announce that the first project that will be supported by the Consortium is on the topic of biologics/biosimilars.  The deliverables of this project will support Alberta Health with managing the translation, implementation, and monitoring of policy developed via a collaborative pan-Canadian process managed by the pCPA.  The project will enable Alberta to realize the expected benefits from the introduction of biosimilars to the health system and the patients it serves. Specifically, it will:

  • support Alberta Health and other stakeholders with pan-Canadian policy direction and principle interpretation/adaptation to the Alberta context in order to inform Alberta biosimilar strategy;
  • provide an implementation framework and supporting resources to assist patients and physicians to utilize biosimilars as intended by policy; and
  • prospectively build an evidence base to inform policy, and provide a monitoring and reporting service regarding outcomes achieved with biosimilars to inform clinical decision-making.

Further information about how stakeholder input will inform this project will be shared when available.